Speech And Language Delay denials in California external review
In the California DMHC record, independent physician reviewers decided 27 published external-review cases involving speech and language delayand overturned the plan’s denial in 77.8%. That is a historical result among cases that reached this program, not a forecast for an individual appeal.
Most-fought treatments for speech and language delay
| Treatment | Decisions | Overturned |
|---|---|---|
| Speech Therapy | 22 | 81.8% |
What the reviewers wrote
Where the denial was overturned
Nature of Statutory Criteria/ Case Summary: The enrollee’s parent is requesting authorization and coverage for three (3) sessions per week of speech therapy co-treatment with occupational therapy, one (1) session per week of speech therapy co-treatment with a behavior technician and one (1) session per month of speech therapy co-treatment with a BCBA. The enrollee has autistic disorder and speech/language delay and receives speech therapy (ST) and occupational therapy (OT). Concerns are related to motor planning/coordination skills and sensory processing differences affecting activities of daily living (ADL) independence. The enrollee is showing measurable gains by his continued progress with goal areas and increased independence in self-care skills. The ST re-evaluation report indicates the enrollee started therapy with two times per week for 30 minutes.
The parent of a two-year-old female enrollee has requested one hour per week of speech therapy and one hour per week of sensory integration focused occupational therapy for treatment of the enrollee’s autism. Findings: The physician reviewer found that with regard to the requested speech therapy, Eikeseth noted that the goal of early identification of speech and language problems is to initiate early intervention, which has been shown to improve outcomes for children who have autism. On average, the young patients who received the behavioral treatment gained 17 IQ points, 13 points in language comprehension, and 23 points in expressive language and 11 points in adaptive behaviors. In comparison, the eclectic treatment group obtained an average of +4 points in IQ, and made no further gains.
Where the denial was upheld
The patient is a five-year-old male with a diagnosis of speech and language delay (expressive and receptive). He also has a diagnosis of auditory processing disorder. He has been receiving speech therapy since July 2003. The record provided for review includes an evaluation from January 2005 and daily progress notes from September 2004 through May 2005. The Health Plan has denied coverage for speech therapy provided from January 2005 through May 2005 based upon a determination that it was not medically necessary.The January progress report indicates the patient was meeting all goals at that time. However, the daily notes only document the treatment that was provided during the session and do not address functional goals. Additionally, the therapist does not perform standardized testing to show progress toward specific goals.
The patient is a seven-year-old male with multiple diagnoses relating to cognition with a primary diagnosis of attention deficit hyperactivity disorder (ADHD). The patient has been seen by a speech therapist who has documented a significant speech and cognitive delay. Additionally, neuropsychological testing has been performed. The patient’s neuropsychologist recommended ongoing speech and language therapy. The Health Plan indicates that continued speech therapy is not medically indicated.Based upon review of the pre-and post-speech therapy documentation, it is apparent the patient has regressed is some areas despite therapy. In addition, there is not sufficient literature evaluating speech therapy as a primary treatment for ADHD. Typically, medications are used as the primary treatment for this disorder with speech therapy used as an adjunctive therapy.
Figures and quotations on this page come from 42,749 published decisions in the California DMHC Independent Medical Review dataset. These are California external-review outcomes. Other state and federal programs have different eligibility rules, processes, and current availability; the rates here do not transfer to those programs or predict an individual result. Excerpts are quoted verbatim from the public record and describe this condition generally, not any individual case.
These outcomes describe eligible cases completed through California DMHC’s Independent Medical Review program. They do not estimate the chance that an internal appeal, an external review in another jurisdiction, or your individual case will succeed. Use the record to identify evidence patterns involving speech and language delay, then check the rights and deadlines that apply to your plan.
SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · AGGREGATES + DEIDENTIFIED DECISION EXCERPTS/REFERENCE IDS · METHODOLOGY